Description

Pack: 1 vial 5000iu + 1 solvent 2ml

Substance: Chorionic Gonadotropin

Brand: BodyPharm

Anovulatory infertility
In the female, HUCOG is used in the treatment of anovulatory infertility. where its administration would form part of recognized treatment regimen involving prior stimulation of follicular maturation and endometrial proliferation e.q. with Menotropin Injection (HUMOG).

In women, HCG is used together with other hormones called follicle stimulating hormone (FSH) and luteinising hormone (LH) in the treatment of infertility.

Normally, in the ovaries in women, FSH increases the number of growing follicles and stimulates their development. Within the follicles are the developing eggs. FSH also increases the production of oestrogen, and under the influence of this hormone, the largest follicle continues to develop. As the amount of oestrogen in the blood increases, this triggers a surge of another hormone called LH, which results in the release of an egg from the ovary (ovulation).

Hypogonadotrophin hypogonadism and cryptorchidism
In the male, HUCOG stimulates the interstitial cells of the testes and consequently the secretion of androgens and the development of secondary sexual characteristics. With concomitant Menotropin Injection therapy, HUCOG stimulates the induction and maintenance of spermatogenesis. The effect of HUCOG in men is to stimulate production of the male hormone, testosterone.